Treatment Action Group
By
Treatment Action Group,
Health GAP,
AIDS-Free World,
Treatment Action Campaign
Published: March 23, 2017, 10:17 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
Treatment Action Group, Health GAP, AIDS-Free World, and Treatment Action Campaign urge G20 leaders to fund research to end TB.
Read More →
By
European AIDS Treatment Group (EATG),
Treatment Action Group
Published: March 16, 2017, 2:27 p.m.·
Tags:
Events
The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) hosted two webinars this month on TB diagnostics and TB treatment, respectively.
Read More →
By
Treatment Action Group
Published: Feb. 15, 2017, 5:17 p.m.·
Tags:
Diagnostics,
Advocacy
The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.
Read More →
By
Treatment Action Group
Published: Nov. 18, 2016, 11:48 p.m.·
Tags:
Events
The symposium was held October 27 at the 2016 Union World Conference on Lung Health in Liverpool, UK.
Read More →
By
Treatment Action Group
Published: Nov. 16, 2016, 4:26 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.
Read More →
By
Treatment Action Group
Published: Nov. 10, 2016, 11:38 a.m.·
Tags:
Advocacy
Cutting-edge science and research are critical to developing new tools to catalyze the end of tuberculosis (TB). The US government plays a vital role in advancing research and development (R&D) for TB, as it is the largest supporter of TB R&D globally. Yet years of flat US government funding for TB R&D have eroded the prospect of new tests, treatments, and a vaccine to combat the rising threat of drug-resistant TB. Urgent advocacy and action are needed to maintain and increase US government funding for TB R&D.
Read More →
By
Treatment Action Group
Published: Oct. 25, 2016, 4:59 a.m.·
Tags:
Global TB response,
Research and development,
Advocacy
Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.
Read More →
Page 15 of 22 · Total posts: 10
←First
14
15
16
Last→